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Abstract
Introduction
Obesity  and  metabolic  syndrome  (MetS)  indicators  have  in-
creased globally among the pediatric population. MetS indicators
in the young elevate their risk of cardiovascular disease and meta-
bolic  disorders  later  in  life.  This  study  examined  early  onset
obesity as a risk factor for MetS risk in adolescence.
Methods
A cohort of Chilean participants (N = 673) followed from infancy
was assessed at age 5 years and in adolescence (mean age, 16.8 y).
Adiposity was measured at both time points; blood pressure and
fasting blood samples were assessed in adolescence only. Early
onset obesity was defined as a World Health Organization z score
of 2 standard deviations (SDs) or more for body mass index (BMI)
at age 5 years. We used linear regression to examine the associ-
ation  between early  onset  obesity  and adolescent  MetS risk  z
score, adjusting for covariates.
Results
Eighteen percent of participants had early onset obesity, and 50%
of these remained obese in adolescence. Mean MetS risk z score in
adolescence was significantly higher among those with early on-
set obesity than among those without (1.0; SD, 0.8 vs 0.2; SD, 0.8
[P < .001]). In the multivariable model, early onset obesity inde-
pendently contributed to a higher MetS risk score in adolescence
(β = 0.27, P < .001), controlling for obesity status at adolescence
and sex, and explained 39% of the variance in MetS risk.
Conclusion
Early onset obesity as young as age 5 years relates to higher MetS
risk.
Introduction
Obesity among children is a global public health problem (1,2),
and signs of metabolic syndrome (MetS) have increased among
both children and adolescents over the past 25 years (3,4). MetS is
defined as having at least 3 of 5 risk factors: a large waist circum-
ference, high blood pressure, fasting hyperglycemia, hypertrigly-
ceridemia, and low high-density lipoprotein (HDL) cholesterol
levels (5). Although few children meet all 5 MetS criteria, up to
30% of obese children have at least one element of MetS (6). A re-
cent systematic review showed a median prevalence of MetS of
3%  (range  0%–19.2%)  among  all  children  and  29%  (range
10%–66%) among obese children (3). In a sample of US adoles-
cents aged 12 to 17 years, the overall MetS prevalence was 7%,
with a range from 19% to 35% among obese adolescents (7). Ad-
ditionally, Hispanic adolescents had a higher MetS prevalence
(11%) than non-Hispanic white adolescents (9%) (8).
MetS increases a person’s risk for  developing chronic disease
(9,10). Pediatric MetS is independently associated with type 2 dia-
betes and adult MetS and with subclinical atherosclerosis leading
to cardiovascular disease (CVD) (11,12). Additionally, research
shows that obesity tracks from childhood into adulthood (13) and
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contributes to adverse consequences, including premature mortal-
ity and cardiometabolic disorders (14,15). However, the impact of
the age of obesity onset in early childhood on adolescent MetS
risk has not been documented, because research has largely fo-
cused on infant weight gain and catch-up growth as predictors of
health outcomes later in life (16–18). This study examined early
onset obesity as a risk factor for MetS risk in adolescence. We hy-
pothesized that obesity onset early in life is associated with a high-
er MetS risk score in adolescence.
Methods
Study design and population
Participants were 677 Chilean infants who were part of an obser-
vational longitudinal study of biopsychosocial determinants of
obesity and CVD risk. From 1991 through 1996, 1,933 infants
were enrolled in either a preventive trial of iron supplementation
to prevent iron-deficiency anemia or a neuromaturation study, a
study that assessed neurodevelopment by using neurophysiologic-
al and electrophysiological techniques. The studies were conduc-
ted in Santiago, Chile, where infancy iron deficiency was wide-
spread at the time and no national program existed for iron supple-
mentation. Infants were from low-to-middle income, working-
class communities. Inclusion criteria for the infancy studies were
an uncomplicated, singleton, term, vaginal birth with birthweights
of 3 kg or more, no major congenital abnormalities, and no prior
iron therapy. Because of a successful national breastfeeding cam-
paign, all but 8 infants in the cohort were initially breastfed.
Infants were recruited at age 4 to 6 months. Infants without iron-
deficiency anemia were randomly assigned to high-iron supple-
mentation, low-iron supplementation, or usual nutrition (no added
iron). Further details about enrollment and trial specifications are
described elsewhere (19). A total of 1,657 infants completed the
preventive trial (high iron, n = 718; low iron, n = 405; usual nutri-
tion, n = 534). Infants found to have iron-deficiency anemia, and
the next nonanemic infant (the control), were treated with medi-
cinal iron and participated the neuromaturation study (20). A total
of  135 infants  completed the neuromaturation study.  At age 5
years, because of a cut in funding, only 2 of the 3 randomly selec-
ted preventive trial groups and neuromaturation trial participants
could be evaluated. Thus, only 888 of 1,501 infants who were in
the high-iron and no-added-iron groups or completed the neur-
omaturation study were assessed. At age 16 years, participants
from the 5-year follow up were invited to participate in a study of
obesity and CVD risk. A total of 677 of 888 (76%) participants
agreed and were assessed from 2009 through 2012. Our analytic
sample for the obesity and MetS study consisted of 673 parti-
cipants from the obesity and CVD risk study who had complete
data at 5 years and 16 years (Figure).
Figure.  Flow of  participants  in  study on relationship between early  onset
obesity  and  metabolic  syndrome  risk  in  adolescence,  Santiago,  Chile,
2009–2012. Participants were drawn from a larger study of infancy iron-
deficiency anemia.
 
The sample was representative of the original cohort, with no dif-
ferences  in  infant  and  family  characteristics,  including  birth-
weight (3.5 kg in the original cohort vs 3.6 kg in the final analytic
sample), breastfeeding for at least 6 months (63% in the original
cohort vs 61% in the final analytic sample), socioeconomic status
(SES) (27.3 on the Graffar index [21] for the original cohort vs
27.0 for the final analytic sample), and household environment
(30.1 on the Home Observation for Measurement of the Environ-
ment [HOME] [22] scale for the original cohort vs 30.0 for the fi-
nal analytic sample). The study was approved by the institutional
review boards of the University of California, San Diego, the Uni-
versity of Michigan, and the University of Chile Institute of Nutri-
tion and Food Technology (INTA).
Data collection and analysis
Participants were considered to have early onset obesity if obesity
was present  at  age 5 years  (defined as  ≥2 standard deviations
[SDs] for body mass index [BMI] z score) by using WHO growth
standard indicators. BMI is a measure of weight relative to height
(kg/m2), with age-specific and sex-specific norms (23).
Adolescents were assessed at age 16 to 17 years.  Height (cm),
weight (kg), waist and hip circumference (cm), and blood pres-
sure (mmHg) were measured by a physician-investigator at INTA.
Standardized  procedures  were  used  to  measure  weight  to  the
closest 0.1 kg by using a SECA scale (SECA), and height to the
closest 0.1 cm by using a Holtain stadiometer (Holtain Ltd) (24).
Each measurement was taken twice, and a third measurement was
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taken if  the difference between the first  2 exceeded 0.3 kg for
weight, 0.5 cm for height, or 1.0 cm for waist. The WHO BMI z
score indicator was used to dichotomize (yes/no) obesity status at
adolescence, with obesity defined as an SD of 2 or more in the
BMI z score. Fasting serum triglyceride, cholesterol, and glucose
levels were assessed. Serum glucose concentration (mg/dL) was
determined by using an enzymatic–colorimetric  test  (Química
Clínica Aplicada S.A.).  Triglyceride (mg/dL),  and cholesterol
(mg/dL) levels were determined with the Vitros dry analytical
methodology (Ortho Clinical Diagnostics Johnson & Johnson Inc).
A continuous MetS risk z score was calculated by applying the
equations developed by Gurka et al (25). The equations provide a
sex-specific and race-specific z score measure for MetS risk based
on standardized and log-transformed values for each component of
the MetS.
Characteristics that may be associated with both the variable of in-
terest and the outcome were considered covariates. For infancy,
the following were considered: birthweight, SES, breastfeeding,
emotional and material support provided in the home environment,
iron status during infancy, and iron supplementation as part of the
preventive trial. For adolescents, the following were potential cov-
ariates: age at menarche, age at the adolescent assessment, physic-
al activity, and obesity status. Birthweight, measured in kilograms,
was analyzed as a continuous measure. Iron status during infancy,
coded as iron sufficient, iron deficient, or iron-deficient anemic,
was dichotomized to iron sufficient (0) and iron deficient or iron-
deficient anemic (1) for modeling purposes. Iron supplementation
in infancy was dichotomized to iron supplementation (high or low)
(1) and no iron supplementation (0). The SES variable, the Graf-
far index, is a pseudocontinuous variable based on a 13-item ques-
tionnaire that produces a composite score that comprises ques-
tions on mothers’ and fathers’ years of education, occupation, and
income (21)  the  higher  the  Graffar  index,  the  lower  the  SES.
Questions were coded as absent (1) to plentiful (6), for a possible
score range of 13 to 78. The quality of the home environment that
supported the children’s development was assessed with HOME, a
45-item, observer-rated checklist (22). A higher HOME score re-
flects a more supportive home environment for children’s devel-
opment. Scores range from 0 to 45. Physical activity at adoles-
cence was measured by using a 5-item questionnaire, validated for
use  in  young  populations  (26).  The  questionnaire  addresses
planned and unplanned physical and sedentary activities as a con-
tinuous score between 0 and 10. Age at menarche and age at ad-
olescent measurement were analyzed as continuous variables.
Statistical analyses
SAS version 9.2 (SAS Institute) was used for all statistical ana-
lyses, with the exception of computed MetS risk score, for which
SPSS version 22.0 (IBM Corp) was used.
For describing sample characteristics, continuous variables were
expressed as mean and SD, and categorical variables were ex-
pressed as frequencies. All variables were assessed for normality.
Unadjusted comparisons between early onset obesity groups were
calculated by using t tests for continuous outcomes and χ2 tests for
categorical  outcomes.  Regression diagnostics,  using tests  and
graphical methods, examined linear regression assumptions in-
cluding  linearity  (residual  vs  predictor  plot)  normality
(Shapiro–Wilk test),  homogeneity of variance (Breusch–Pagan
test) and independence (Durbin–Watson statistic). All of these as-
sumptions were met, indicating linearity, uncorrelated and nor-
mally distributed estimated residuals with constant variance. Influ-
ence and collinearity were also examined, with no extreme devi-
ations observed for studentized and jackknife residuals, and small
leverage and Cook’s distance values. Multivariable linear regres-
sion analysis was used to assess the relationship between early on-
set  obesity  and  MetS  risk  score,  adjusting  for  possible  con-
founders. The full model was tested by using backward elimina-
tion. Variables that were not statistically associated with the de-
pendent  variable  were  manually  removed.  Because  the  study
sample participated in a preventive trial,  iron status during in-
fancy and iron supplementation were initially included as covari-
ates. Neither variable was significantly associated with the out-
come, and thus both were removed from the final model. Age at
menarche, which was tested in the multivariable model, was not
significantly associated with outcome and therefore was dropped
from the final model. Significance was set at a P value of less than
.05. Multicollinearity between variables was assessed with toler-
ance level with a cut point of less than 0.10. There was no evid-
ence of multicollinearity in the model.
Marginal structural models (MSMs) refine the adjustment made
by traditional analytic approaches and predict an estimate that ac-
counts for the bias that exists when time-dependent covariates
might act as both confounders and intermediates in a linear associ-
ation. We used an MSM as a sensitivity analysis to account for po-
tential bias resulting from the inclusion of adolescent weight status
in the final model; bias may arise because adolescent weight status
both mediates and confounds the relationship between early-life
obesity and adolescent MetS risk score. To carry out these ana-
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lyses, we estimated stabilized inverse probability weights (27) and
reweighted our sample to create a pseudopopulation in which the
exposure, early onset obesity, is statistically independent of poten-
tial time-dependent confounders. Results from the pseudopopula-
tion models supported initial findings, indicating limited bias res-
ulting from the inclusion of adolescent weight status as a covari-
ate in the multivariable linear regression model.
Results
Mean  age  of  participants  at  adolescence  was  16.8  years,  and
52.9% were male (Table 1). The mean birthweight in the study
population was 3.6 kg (SD, 0.4 kg). Early onset obesity was found
in 18.1% of the participants, of which 41.0% were girls. We found
no significant differences in birthweight, sex, SES, HOME scores,
and physical activity in adolescence between participants with
early onset obesity and participants without early onset obesity.
Obesity status at adolescence was related to early onset obesity. Of
those with early onset obesity, 50% were obese at adolescence, in
contrast to 6% of the comparison group (P < .001).
The MetS risk score and all variables related to CVD risk were
significantly higher in the early onset obesity group, compared
with the group without early onset obesity, with the exception of
HDL cholesterol, which was inversely related to CVD risk, and
fasting blood glucose, which did not differ between groups (Table
2). Participants in the early onset obesity group had significantly
higher mean total cholesterol levels (156.4 mg/dL; SD, 27.9 vs
151.1 mg/dL; SD 27.5, P = .04) and low-density lipoprotein cho-
lesterol levels (98.9 mg/dL, SD 24.8 vs 93.3 mg/dL, SD 24.2, P =
.03) compared with the group without early onset obesity. Addi-
tional analyses for MetS components by sex showed that adoles-
cent boys had significantly lower mean total cholesterol and HDL
cholesterol levels and significantly higher fasting blood glucose
levels and blood pressure than adolescent girls.
The final model, controlling for sex and obesity status in adoles-
cence, indicated that early onset obesity was associated with a
higher MetS risk score in adolescence (β = 0.27; 95% confidence
interval [CI] 0.13– 0.41, P < .001) (Table 3) and explained 39% of
the variance in the MetS risk score. The adjusted mean and stand-
ard error (SE) MetS risk score was 1.0 (SE, 0.06) and 0.7 (SE,
0.04) for participants with and without early onset obesity, re-
spectively. Additionally, female sex was associated with a lower
MetS risk score in the model (β = −0.26; 95% CI, −0.35 to −0.17;
P < .001), adjusting for other covariates.
Findings from the MSM, a sensitivity analysis, did not differ from
findings of the multivariable regression analysis. This corrobor-
ated the effect size of early onset obesity and its relationship with
MetS risk score in adolescence.
Discussion
This study showed that early onset obesity was associated with
greater  MetS  risk  in  adolescence.  Independent  of  adolescent
obesity status and sex, a child who had obesity at age 5 years had a
higher MetS risk score (β = 0.27) at age 16. These results support
our initial hypothesis.
Our findings are consistent with those in a mid-childhood cohort
(28). Using a similar analytic approach and focusing on metabolic
profiles that included dyslipidemia, hypertension, and insulin res-
istance, Garnett et al. (28) concluded that children who were over-
weight or obese at age 8 years were almost 7 times as likely to
have CVD risk-clustering at age 15 years as those who were not
overweight or obese (odds ratio, 6.9; 95% CI, 2.5– 19.0; P < .001)
(28).
Boys in our cohort had higher mean MetS risk scores than girls,
independent of early onset obesity and obesity status at adoles-
cence.  These results  are similar  to our prior  findings (29) and
those of US national data, in which adolescent boys were more
likely to have MetS risk factors than adolescent girls (9). A recent
systematic review of the prevalence of MetS in children and ad-
olescents from 12 countries in North America and South America
also found a higher prevalence of MetS among boys (29). Adoles-
cent boys also manifested higher fasting blood glucose, higher
blood pressure, and lower HDL cholesterol levels than adolescent
girls.  These  CVD  risks  were  primarily  observed  in  Mexico,
Canada, Colombia, and the United States (30).
This research emphasizes the value of studying longitudinal co-
horts  and the relevance this  study’s  cohort  to  obesity  in  early
childhood and adolescent health outcomes among Chileans. In ad-
dition  to  the  longitudinal  study design,  this  study has  several
strengths, such as the uniqueness of a Chilean cohort of infants
followed successfully to adolescence,  inclusion of a relatively
large group of healthy infants, and good participant retention. An-
other strength is that the evaluation was conducted at a nutrition
research center by highly trained study personnel. Furthermore,
the use of a sex-specific and race-specific continuous MetS risk
score is a study strength. Although continuous scores were previ-
ously developed, the methodology followed by Gurka et al and ap-
plied in this study, acknowledges correlations between the MetS
components, accounting for MetS component correlation differ-
ences by sex and race/ethnicity (25).
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A limitation of this study is that it may not be generalizable to oth-
er populations. The participant sample was restricted to infants
who weighed 3 kg or more at birth. Thus, we cannot infer whether
these relationships translate to preterm or low-birthweight infants.
Also, probably because data on birthweight were restricted, we
probably did not observe a relationship between birthweight and
obesity. Generalization to higher-income or poverty groups is also
restricted.  Another  limitation  is  lack  of  anthropometric  data
between measurement waves, thus placing participants in a BMI
category at time of measurement, which might have been differ-
ent a year before or after measurement. Additionally, data were
unavailable on maternal or paternal obesity status, diet intake, and
direct physical activity measures. Although we attempted to min-
imize unmeasured confounding in our study by including meas-
ures on recognized potential confounders, such unmeasured risk
factors  could  confound  the  relationship  between  early  onset
obesity and MetS risk.
Notwithstanding these limitations, our findings add to the literat-
ure on early life determinants, in particular determinants related to
the  long-term effects  of  early  onset  obesity  on  MetS or  other
CVD-related risk factors. Future research should be conducted in
populations with various races and ethnicities to substantiate these
findings and address a key public health problem.
Our results  underscore  the public  health  implications  of  early
childhood obesity for health outcomes later in life. The findings
provide evidence for a clinically meaningful and significant asso-
ciation between early onset obesity and MetS risk score in this
Chilean cohort. The results of this study emphasize the import-
ance and need for early detection of childhood obesity and effect-
ive public health interventions.
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Tables
Table 1. Characteristics of Participants (N = 673), Study of Relationship Between Early Onset Obesity and Risk of Metabolic Syndrome Among Adolescentsa, Santi-
ago, Chile, 1991–1996 and 2009–2012
Characteristic Total Sample (n = 673) Early Onset Obesity (n = 122) No Early Onset Obesity (n = 551) P Valueb
Infancy
Birthweight, mean (SD), kg 3.6 (0.4) 3.6 (0.4) 3.5 (0.4) .67
Male, % 52.9 59.0 51.5 .13
Breastfeed ≥6 months, % 63.4 63.6 63.3 .96
Iron status during infancy, %
Iron sufficient 41.5 34.4 43.0
.06Iron deficient 40.1 40.2 40.1
Iron deficiency anemia 18.4 25.4 16.9
Socioeconomic status, Graffar
indexc, mean (SD)
27.0 (6.3) 27.0 (6.2) 27.0 (6.3) .87
HOME scored, mean (SD) 30.2 (4.7) 30.2 (4.8) 30.2 (4.7) .90
Supplementation group, %
High iron 47.2 45.9 47.6
.96
Low iron 2.7 3.3 2.5
No added iron 42.1 42.6 41.9
Neuromaturation studye 8.0 8.2 8.0
Adolescence
Age at menarchef, mean (SD), y 12.5 (1.4) 12.0 (1.4) 12.5 (1.4) .01
Age at adolescent measurement, y 16.8 (0.3) 16.8 (0.3) 16.8 (0.3) .48
Physical activity scoreg, mean (SD) 4.1 (1.6) 4.0 (1.5) 4.1 (1.7) .38
Obesity at 16 yh, % 14.1 50.0 6.2 <.001
Abbreviations: SD, standard deviation; HOME, home observation for measurement of the environment.
a Early onset obesity defined as obese at 5 years of age following World Health Organization z score cut-off ≥2 SD body mass index (kg/m2).
b P value for χ2 test for categorical variables and t test for continuous variables.
c Graffar index is a social stratification tool used to assess socioeconomic status (range 13-78); the higher the Graffar index, the lower the socioeconomic status
(21).
d HOME score (range 0-45) is a home environment quality assessment tool; the higher the HOME score, the better the home environment for child development
(22).
e Participants in the neuromaturation study were infants found to have iron-deficiency anemia at age 6 months, and the next nonanemic infant (control) whose
neurodevelopment was evaluated with neurophysiological and electrophysiological techniques (20).
f Female participants only.
g Physical activity score (range 0-10) assessing planned and unplanned physical and sedentary activities (26).
h Obesity at 16 years defined as obese at 16-year follow-up according to the World Health Organization z score cut-off ≥2 SD for body mass index.
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Table 2. Metabolic Syndrome Risk Scorea and Cardiovascular Disease Risk Factors Among Participants (N = 673), Study of Relationship Between Early Onset
Obesityb and Risk of Metabolic Syndrome Among Adolescents, Santiago, Chile 1991–1996 and 2009–2012c
Variable Total Population (N = 673) Early Onset Obesity (n = 122) No Early Onset Obesity (n = 551) P Valued
Metabolic syndrome risk z score 0.3 (0.8) 1.0 (0.8) 0.2 (0.8) <.001
Waist circumference, cm 81.3 (11.4) 94.0 (12.5) 78.5 (9.0) <.001
HDL cholesterol, mg/dL 40.2 (10.6) 37.1 (9.5) 40.9 (10.7) <.001
Triglycerides, mg/dL 88.2 (50.0) 103.3 (57.2) 84.8 (47.7) .001
Systolic blood pressure, mm Hg 111.7 (10.5) 117.5 (11.7) 110.4 (9.8) <.001
Diastolic blood pressure, mm Hg 69.1 (7.1) 71.9 (7.2) 68.5 (6.9) <.001
Fasting blood glucose, mg/dL 88.6 (9.5) 89.5 (12.2) 88.5 (8.8) .36
Abbreviations: HDL, high-density lipoprotein.
a Metabolic syndrome risk z score calculated with sex-specific and race-specific equations with confirmatory factor analysis.
b Early onset obesity defined as obese at age 5 years according to World Health Organization z score cut-off ≥2 standard deviations for body mass index (kg/m2).
c Values are unadjusted mean (standard deviation) unless otherwise indicated.
d P values calculated with t test for continuous variables for differences between the early onset obesity group and no early onset obesity group.
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Table 3. Linear Regression Models to Determine Adjusted Associations With Participants’ (N = 673) Metabolic Syndrome Risk Scorea, Study of Relationship
Between Early Onset Obesity and Risk of Metabolic Syndrome Among Adolescents, Santiago, Chile 2009–2012
Variable
Full Modelb Final Modelb
β (95% CI) P Valuec β (95% CI) P Valuec
Early onset obesityd 0.29 (0.15 to 0.44) <.001 0.27 (0.13 to 0.41) <.001
Obesity at 16 ye 1.18 (1.02 to 1.34) <.001 1.20 (1.04 to 1.35) <.001
Femalef −0.29 (−0.40 to −0.18) <.001 −0.26 (−0.35 to −0.17) <.001
Birthweight, kg 0.08 (−0.05 to 0.21) .23 — —
Breastfed ≥6 months 0.01 (−0.09 to 0.11) .83 — —
Iron deficient during infancyg −0.02 (−0.12 to 0.08) .73 — —
Iron supplementationh 0.05 (−0.05 to 0.15) .35 — —
Graffar indexi 0.004 (−0.01 to 0.01) .32 — —
HOME scorej 0.003 (−0.01 to 0.01) .54 — —
Age at menarchek −0.01 (−0.06 to 0.05) .83 — —
Age at adolescent measurement −0.02 (−0.20 to 0.18) .86 — —
Physical activity scorel −0.03 (−0.06 to 0.01) .10 — —
Abbreviations: —, not calculated for parsimony; CI, confidence interval; HOME, home observation for measurement of the environment.
a Metabolic syndrome risk score calculated with sex-specific and race-specific equations with confirmatory factor analysis.
b Linear regression modeling, presenting β estimate and 95% confidence interval.
c P values calculated by linear regression modeling, adjusted for all other listed variables in each of the models (full and final).
d Early onset obesity defined as obese at age 5 years according to World Health Organization z score cut-off ≥2 standard deviations for body mass index (kg/m2).
Reference: no early onset obesity.
e Obesity at age 16 years defined as obese at 16-year follow-up according to World Health Organization z score cut-off ≥2 standard deviations for body mass index.
Reference: no obesity at age 16 years.
f Reference: male.
g Includes iron deficient and iron deficiency anemia. Reference: iron sufficient.
h Iron supplementation includes: high-iron and low-iron supplementation during trial. Reference: no iron supplementation.
i Graffar index is a social stratification tool used to assess socioeconomic status (range 13-78); the higher the Graffar index, the lower the socioeconomic status
(21).
j HOME score (range 0-45) is a home environment quality assessment tool; the higher the HOME score, the better the home environment for child development
(22).
k Age at menarche for female participants.
l Physical activity score (range 0-10) assessing planned and unplanned physical and sedentary activities (26).
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